H.R. 184 the Protect Medical Innovation Act which would repeal the Medical Device Excise Tax passed in the U.S House of Representatives on July 24, 2018. (283 Ayes; 132 Nayes; 13 Not Voting) Seven members of Arizona’s nine person House Delegation both co-sponsored and voted in support of of the bill. The next step is the Senate. Continue reading
Category Archives: Advocacy and Regulations
Update – Proposed Continuing Resolution in the U.S. House and Medical Device Tax Suspension
The countdown clock is ticking on the status of federal funding and the end of the two-year suspension of the medical device tax. First payments on the medical device tax are due to be made in just 12 days.Continue reading
Draft Legislation for User Fee Reauthorization Released on April 14, 2017
On April 14, 2017, the leaders of the Senate and House health committees released a discussion draft of bipartisan legislation reauthorizing the Food and Drug Administration user fee agreements. Continue reading
Sharing Arizona Bioindustry News in Washington DC
AZBio delivered data on life-changing innovation and the economic impact of Arizona’s life sciences industry to Arizona’s Congressional Delegation last week in meetings with 10 of Arizona’s 11 Congressional offices.
Understanding Gov. Ducey’s $1 billion university research infrastructure plan
Building on Success for a Better Arizona – Your Letter Can Make a Difference – Click Here to Learn More
Bill to Streamline CMS’s Process for Breakthrough Technologies Introduced in the US Senate
The Ensuring Patient Access to Critical Breakthrough Products Act, will help bridge a gap between FDA and CMS and improve patient access to breakthrough medical technologies for serious illnesses, S. 2998, to expedite CMS decision-making for innovative medical technologies.Continue reading
Arizona Governor Ducey Signs Bill Ensuring Patient Access to Interchangeable Biologic Medicines
Communication Important for Patients and PhysiciansContinue reading
Arizonans advocating for a more accurate test for Lyme Disease
Focus On Lyme executive director to speak at Capitol Hill science forum. Arizona-based group advocates for a definitive test for Lyme disease being developed by TGenContinue reading
AZBio Watch List for April 25 2016
Learn more about the bills AZBio is tracking at the Arizona Legislature
Continue reading
HB 2310- Getting Ready for Biosimilars in Arizona
The FDA approved the first biosimilar in the U.S. in March of 2015 with more expected to be approved in 2016. Now, on a state by state basis, the laws that govern how these new therapies can be dispensed are being updated. Arizona has the opportunity to do so in 2016 with HB 2310 sponsored by Dr. Regina Cobb, Vice Chairman of the House Health Committee.Continue reading